News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,588 Results
Type
Article (771)
Company Profile (2)
Press Release (815)
Section
Business (501)
Career Advice (1)
Deals (68)
Drug Delivery (1)
Drug Development (829)
FDA (102)
Job Trends (141)
News (1051)
Policy (361)
Tag
Academia (26)
Alliances (176)
ALS (1)
Alzheimer's disease (3)
Antibody-drug conjugate (ADC) (11)
Approvals (91)
Artificial intelligence (7)
Best Places to Work (136)
BIOSECURE Act (1)
Biosimilars (1)
Biotechnology (2)
Brain cancer (1)
Breast cancer (8)
Cancer (59)
Cardiovascular disease (2)
Career advice (2)
Career pathing (1)
CAR-T (1)
CDC (5)
Cell therapy (6)
Clinical research (307)
Collaboration (9)
Complete response letters (2)
COVID-19 (507)
C-suite (7)
Cystic fibrosis (1)
Data (12)
Denatured (3)
Diagnostics (46)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (168)
Editorial (6)
Events (139)
Executive appointments (1)
FDA (108)
Funding (9)
Gene editing (2)
Gene therapy (7)
GLP-1 (18)
Government (194)
Guidances (2)
Healthcare (129)
Huntington's disease (1)
Immunology and inflammation (3)
Immuno-oncology (2)
Infectious disease (512)
Influenza (3)
IPO (32)
IRA (2)
Job creations (11)
Job search strategy (2)
JPM (5)
Labor market (1)
Layoffs (9)
Legal (48)
Lung cancer (20)
Manufacturing (7)
MASH (1)
Medical device (14)
Medtech (14)
Mergers & acquisitions (38)
Metabolic disorders (13)
Neuroscience (4)
NextGen: Class of 2026 (9)
Non-profit (8)
Obesity (11)
Opinion (4)
Pancreatic cancer (1)
Patents (6)
Patient recruitment (1)
People (129)
Phase 1 (153)
Phase 2 (180)
Phase 3 (194)
Pipeline (22)
Policy (16)
Postmarket research (2)
Preclinical (59)
Prostate cancer (1)
Psychedelics (3)
Radiopharmaceuticals (2)
Rare diseases (9)
Real estate (14)
Regulatory (188)
Research institute (39)
RSV (3)
Series A (1)
Series B (3)
Sickle cell disease (1)
Special edition (2)
Startups (10)
Tariffs (1)
The Weekly (10)
Vaccines (194)
Venture capital (2)
Weight loss (3)
Date
Last 7 days (1)
Last 30 days (9)
Last 365 days (128)
2026 (9)
2025 (129)
2024 (167)
2023 (165)
2022 (293)
2021 (354)
2020 (342)
2019 (43)
2018 (29)
2017 (15)
2016 (14)
2015 (14)
2014 (3)
2013 (4)
2012 (7)
Location
Africa (14)
Asia (148)
Australia (7)
California (2)
Canada (4)
China (11)
Colorado (1)
Delaware (1)
Europe (680)
Florida (1)
Indiana (1)
Maryland (11)
Massachusetts (15)
New Jersey (7)
New York (14)
Northern California (1)
Ohio (1)
Pennsylvania (1)
South America (5)
United States (55)
1,588 Results for "biontech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Pfizer Makes $530M Vaccine Play With Novavax Deal After Rumors of BioNTech Pullback
In November, Pfizer was reportedly looking to divest its stake in BioNTech, though the German biotech at the time denied these rumors.
January 20, 2026
·
1 min read
·
Tristan Manalac
Vaccines
Pfizer Reportedly Planning To Divest BioNTech Stake
A BioNTech spokesperson downplayed the news, insisting that the two companies remain “close” and have a “strong collaboration.”
November 14, 2025
·
2 min read
·
Tristan Manalac
Drug Development
BioNTech’s Multi-Modality Play Outpaces Moderna’s mRNA-Focused Pipeline
After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.
February 3, 2026
·
5 min read
·
Nick Paul Taylor
Press Releases
BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer
January 29, 2026
·
6 min read
Layoffs
BioNTech Cuts 90 Jobs Amid ‘Strategic Alignment’
BioNTech also laid off 63 employees in June in conjunction with the discontinuation of its cell therapy manufacturing operations in Gaithersburg, Maryland.
August 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
·
6 min read
Press Releases
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
December 4, 2025
·
13 min read
Mergers & acquisitions
BioNTech Swallows Vaccine Rival CureVac in $1.25B All-Stock Acquisition
BioNTech will get CureVac’s early-stage cancer assets, including its mRNA-based glioblastoma therapy currently in Phase I development. CureVac had previously sued BioNTech for copyright infringement related to mRNA vaccine technology.
June 12, 2025
·
3 min read
·
Tristan Manalac
Press Releases
BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
·
13 min read
Legal
BioNTech Attacked CureVac’s ‘Failed’ COVID Vaccine Program. The Rivals Are Now Merging
BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to bring to market any product to help in the fight against COVID-19.” Now, the mRNA biotech is buying that very company.
June 18, 2025
·
4 min read
·
Nick Paul Taylor
1 of 159
Next
